Being Alive Newsletter, Being Alive/Los Angeles - May 1993
John Lewis
I feel optimal delivery of AP to the lungs depends on both the inhalation technique and the pulmonary function of the recipient. These factors will determine the quantity of aerosol deposition and its distribution in the respiratory tract.
The goal of AP is to enhance the deposition of pentamidine to all aspects of the lung fields. Yet some 20-30% of all patients using AP will develop PCP in the upper lobes after receiving AP. I suggest this is due primarily to an improper breathing technique being used.
930501
BA930527
Copyright © 1993 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/